|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thrombophilia panel
Test CodeCPT Codes
81240, 81241, 85613, 85730, 86146 (x3), 86147 (x3)<br>Restricted Client Code
Includes
Lupus Anticoagulant Evaluation with Reflex
Cardiolipin Ab (IgA, IgG, IgM)
Beta-2-Glycoprotein I Antibodies (IgG, IgA, IgM)
Factor V (Leiden) Mutation Analysis (performed at Quest San Juan Capistrano)
Prothrombin (Factor II) 20210G>A Mutation Analysis (performed at Quest San Juan Capistrano)
If PTT-LA Screen is prolonged (>40 seconds), then Hexagonal Phase Confirmation will be performed at an additional charge (CPT code(s): 85598).
If Hexagonal Phase Confirmation is positive or weakly positive, then Thrombin Clotting Time will be performed at an additional charge (CPT code(s): 85670).
If dRVVT Screen is prolonged (>45 seconds), then dRVVT Confirm will be performed at an additional charge (CPT code(s): 85597).
If dRVVT Confirm is positive, then dRVVT 1:1 Mixing Study will be performed at an additional charge (CPT code(s): 85613).
If the dRVVT Confirmation is positive, a dRVVT 1:1 dilution will be performed at an additional charge (CPT: 85613).
Preferred Specimen
13 mL plasma collected in a sodium citrate 3.2% (light blue-top) tube
Minimum Volume
Other Acceptable Specimens
Transport Temperature
Plasma: Frozen
Specimen Stability
Room temperature: 8 days
Refrigerated: 8 days
Frozen: 30 days
Plasma
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Immunoassay • Photometric Clot Detection
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Reference Range

